Mutual up-regulation of thyroid hormone and parathyroid hormone receptors in rat osteoblastic osteosarcoma 17/2.8 cells

Endocrinology

Volumn 142, Issue 1, 2001, Pages 157-164

  Gu, Wen Xia ^b   Stern, Paula H ^a   Madison, Laird D ^b   Du, Guo Guang ^a,b  

^a Department of Molecular Pharmacology and Biological Chemistry ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BINDING PROTEIN; CALCIUM IONOPHORE; CELL NUCLEUS RECEPTOR; CYCLIC AMP DERIVATIVE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MEMBRANE RECEPTOR; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; THYROID HORMONE; THYROID HORMONE RECEPTOR;

ARTICLE; BONE DISEASE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE RESPONSE; ENZYME ACTIVITY; HORMONE RELEASE; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REGULATORY MECHANISM; WESTERN BLOTTING;

EID: 0035114989     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.1.7905     Document Type: Article

References (39)

1. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation
2. Bone mineralization and calcitropic hormones in children with hyperthyroidism: Effect of methimazole therapy
3. Osteoporosis and fractures following thyrotoxicosis
4. PTH (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum
5. Human PTH (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats
6. Comparative response to parathyroid hormone in hyperthyroidism and hypothyroidism
7. Concomitant Graves' disease and primary hyperparathyroidism influence of hyperthyroidism on serum calcium and parathyroid hormone
8. Coexistence of primary hyperparathyroidism and thyroid disease
9. 3, vitamin D3, and retinoid signaling
10. Down-regulation of the PTH/PTHrP receptor by vitamin D3 in the osteoblast-like ROS 17/2.8 cells
11. Triiodothyronine stimulates proliferation of osteoblast-like cells in serum-free culture
12. Effects of triiodothyronine on DNA synthesis and differentiation markers of normal human osteoblast-like cells in vitro
13. Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells (ROS 17/2.8) through 3,5,3′-triiodo-L-thyronine nuclear receptors
14. Nuclear thyroid hormone receptors in cultured bone cells
15. Anabolic effects of 3,3′,5-triiodothyronine and triiodothyroacetic acid in cultured neonatal mouse parietal bones
16. Insulin-like growth factor-I mediates selective anabolic effects of parathyroid hormone in bone cultures
17. The proliferative effect of parathyroid hormone on osteoblast-like ROS 17/2.8 cells
18. Glucocorticoids increase parathyroid hormone receptors in rat osteoblastic osteosarcoma cells (ROS 17/2)
19. Regulation of parathyroid hormone (PTH/PTH-related peptide) receptor messenger ribonucleic acid by glucocorticoids and PTH in ROS 17/2.8 and OK cells
20. Transforming growth factor-β1 regulates steady-state PTH/PTHrP receptor mRNA levels and PTHrP binding in ROS 17/2.8 osteosarcoma cells
21. 1,25-Dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: Relationship to adenylate cyclase activation
22. Specific down-regulation of parathyroid hormone (PTH) receptors and responses to PTH by tumor necrosis factor α and retinoic acid in UMR 106-06 osteoblast-like osteosarcoma cells
23. Insulin stimulates thyroid hormone receptor alpha gene expression in cultured bovine aortic endothelia cells
24. Regulation of neuronal thyroid hormone receptor alpha 1 mRNA by hydrocortisone, thyroid hormone and retinoic acid
25. Interleukin 1 beta, tumor necrosis factor-alpha and interleukin 6 decrease nuclear thyroid hormone receptor capacity in a liver cell line
26. Insulin-like growth factor 1 production is essential for anabolic effects of thyroid hormone in osteoblasts
27. Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone
28. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators
29. Estrodiol suppresses phosphorylation of cyclic adenosine 3′,5′-monophosphate response element binding protein (CREB) in the pituitary: Evidence for indirect action via gonadotrophin-releasing hormone
30. Gonadotropin-releasing hormone regulates follicle-stimulating hormone-β gene expression through the activin/follistatin autocrine or paracrine loop
31. Modulation by retinoic acid of 1,25-dihydroxyvitamm D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteosarcoma cell line
32. Endothelin B receptor activation enhances parathyroid hormone-induce calcium signals in UMR 106 cells
33. Parathyroid hormone induces c-fos promoter activity in osteoblast cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE
34. Beta 1 adrenergic receptor and G alpha S mRNA in rat heart as a function of mechanical load and thyroxine intoxication
35. Receptors for parathyroid hormone and parathyroid hormone related peptide: Exploration of their biological importance
36. Molecular cloning and characterization of the promoter region of the human c-erb A alpha gene
37. Cloning and characterization of the human thyroid hormone receptor β gene promoter
38. Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities
39. Sequence and activity of parathyroid hormone/parathyroid hormone-related protein receptor promoter region in human osteoblast-like cells